|
Market Closed -
London S.E.
16:35:15 01/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 1,871.50 GBX | +0.97% |
|
-1.78% | +2.58% |
| 09-01 | Gsk Advances Mrna Flu Vaccine Candidate to Phase Iii Following Positive Phase Ii Data | CI |
| 09-01 | European Stocks Close Mostly Lower in Tuesday Trading; Euro Area Inflation Surges in August | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 101B | |||||
| 1,034B | |||||
| 654B | - | - | |||
| 459B | |||||
| 343B | |||||
| 307B |
- Stock Market
- Stocks
- GSK Stock
- Charts GSK plc
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
